Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs.
Jun WuXing ZhouYuanqing TanLiu WangTianda LiZhongwen LiTingting GaoJiaqi FanBaojie GuoWei LiJie HaoXianguang WangBao-Yang HuPublished in: Cell proliferation (2020)